AI Verdict
HRMY has stronger fundamentals based on our AI analysis.
HRTX vs HRMY Fundamental Comparison
| Metric | HRTX | HRMY |
|---|---|---|
| Revenue | $154.9M | $868.5M |
| Net Income | $-20.2M | $158.7M |
| Net Margin | -13.0% | 18.3% |
| ROE | -140.9% | 18.2% |
| ROA | -7.9% | 12.5% |
| Current Ratio | 2.48x | 3.60x |
| Debt/Equity | 0.00x | 0.19x |
| EPS | $-0.12 | $2.71 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HRTX vs HRMY: Frequently Asked Questions
Is HRTX or HRMY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HRMY has stronger fundamentals. HRTX is rated STRONG SELL (87% confidence) while HRMY is rated BUY (78% confidence). This is not investment advice.
How does HRTX compare to HRMY fundamentally?
HERON THERAPEUTICS, INC. /DE/ has ROE of -140.9% vs Harmony Biosciences Holdings, Inc.'s 18.2%. Net margins are -13.0% vs 18.3% respectively.
Which stock pays higher dividends, HRTX or HRMY?
HRTX has a dividend yield of N/A or no dividend while HRMY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HRTX or HRMY for long term?
For long-term investing, consider that HRTX has STRONG SELL rating with 87% confidence, while HRMY has BUY rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HRTX vs HRMY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HRTX vs HRMY, the AI consensus favors HRMY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.